 Zensar Technologies Ltd reports higher consolidated PAT of Rs. 182.2 crores in Q2FY26
Zensar Technologies Ltd reports higher consolidated PAT of Rs. 182.2 crores in Q2FY26 Chemfab Alkalis Ltd consolidated Q2FY26 loss at Rs. 2.01 crore
Chemfab Alkalis Ltd consolidated Q2FY26 loss at Rs. 2.01 crore National Plastic Technologies Ltd Q2 FY2026 PAT increases to Rs. 2.70 crore
National Plastic Technologies Ltd Q2 FY2026 PAT increases to Rs. 2.70 crore NOCIL Ltd Q2 FY2025-26 consolidated profit declines to Rs. 12.12 crores
NOCIL Ltd Q2 FY2025-26 consolidated profit declines to Rs. 12.12 crores IFB Agro Industries Ltd consolidated Q2FY26 net profit surges to Rs. 22.70 crores
IFB Agro Industries Ltd consolidated Q2FY26 net profit surges to Rs. 22.70 crores 
              The Board of Directors of Venus Remedies Ltd at its meeting held on February 08, 2017, has allotted 9,00,000 warrants fully convertible into equity shares to promoters on preferential basis.
Shares of VENUS REMEDIES LTD. was last trading in BSE at Rs.104.1 as compared to the previous close of Rs. 104.65. The total number of shares traded during the day was 7564 in over 150 trades.
The stock hit an intraday high of Rs. 106 and intraday low of 103.9. The net turnover during the day was Rs. 792759.